Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125821861 | 12582186 | 1 | I | 20160711 | 20160722 | 20160722 | PER | US-ASTRAZENECA-2016SE75698 | ASTRAZENECA | 0.00 | F | Y | 0.00000 | 20160722 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125821861 | 12582186 | 1 | PS | TUDORZA PRESSAIR | ACLIDINIUM BROMIDE | 1 | Respiratory (inhalation) | 400 MCG 1 PUFF TWICE A DAY | 202450 | INHALATION POWDER | |||||||||
| 125821861 | 12582186 | 2 | SS | TUDORZA PRESSAIR | ACLIDINIUM BROMIDE | 1 | Respiratory (inhalation) | 400 MCG 1 PUFF TWICE A DAY | 202450 | INHALATION POWDER | |||||||||
| 125821861 | 12582186 | 3 | SS | ATENOLOL. | ATENOLOL | 1 | Oral | 0 | 25 | MG | QD | ||||||||
| 125821861 | 12582186 | 4 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 0 | |||||||||||
| 125821861 | 12582186 | 5 | SS | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Respiratory (inhalation) | 0 | |||||||||||
| 125821861 | 12582186 | 6 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 0 | 40 | MG | QD | ||||||||
| 125821861 | 12582186 | 7 | C | TYLENOL | ACETAMINOPHEN | 1 | Oral | 0 | |||||||||||
| 125821861 | 12582186 | 8 | C | ALBUTEROL. | ALBUTEROL | 1 | Respiratory (inhalation) | 0.083 PERCENT 2.5 MG/ML NEBULIZER PRN | 0 | ||||||||||
| 125821861 | 12582186 | 9 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | Oral | 0.5 MG HALF TAB TID PRN | 0 | ||||||||||
| 125821861 | 12582186 | 10 | C | BUPROPION. | BUPROPION | 1 | Oral | 0 | 150 | MG | QD | ||||||||
| 125821861 | 12582186 | 11 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | Oral | 0 | 2000 | IU | QD | ||||||||
| 125821861 | 12582186 | 12 | C | CRANBERRY EXTRACT | CRANBERRY JUICE | 1 | Oral | 0 | 4200 | MG | QD | ||||||||
| 125821861 | 12582186 | 13 | C | DOCUSATE SODIUM. | DOCUSATE SODIUM | 1 | Oral | 0 | 100 | MG | BID | ||||||||
| 125821861 | 12582186 | 14 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | Nasal | 1 SPRAY EACH NOSTRIL DAILY | 0 | ||||||||||
| 125821861 | 12582186 | 15 | C | LIDOCAINE. | LIDOCAINE | 1 | Topical | 0 | |||||||||||
| 125821861 | 12582186 | 16 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | Oral | 0 | 10 | MG | QD | ||||||||
| 125821861 | 12582186 | 17 | C | MULTIVITAMIN | VITAMINS | 1 | Oral | DAILY | 0 | ||||||||||
| 125821861 | 12582186 | 18 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 0 | 10 | MG | QD | ||||||||
| 125821861 | 12582186 | 19 | C | SENNA | SENNA LEAFSENNOSIDESSENNOSIDES A AND B | 1 | Oral | 8.6 MG 2 TABS AT NIGHT | 0 | ||||||||||
| 125821861 | 12582186 | 20 | C | TRAVATAN | TRAVOPROST | 1 | Intraocular | 0.004 PERCENT OPTHALMIC SOLUTION 1 DROP BOTH EYES | 0 | ||||||||||
| 125821861 | 12582186 | 21 | C | BRIMONIDINE | BRIMONIDINE TARTRATE | 1 | Intraocular | 0.2 PERCENT OPTHALMIC SOLUTION 1 DROP LEFT EYE AM AND NIGHT | 0 | ||||||||||
| 125821861 | 12582186 | 22 | C | PROAIR HFA | ALBUTEROL SULFATE | 1 | Respiratory (inhalation) | 90 MCG 2 PUFFS EVERY 4 TO 6 HRS PRN | 0 | ||||||||||
| 125821861 | 12582186 | 23 | C | ACETAMINOPHEN AND CODEINE | ACETAMINOPHENCODEINE PHOSPHATE | 1 | 300/30 MG, EVERY 3 TO 4 HRS PRN | 0 | |||||||||||
| 125821861 | 12582186 | 24 | C | ACETAMINOPHEN AND CODEINE | ACETAMINOPHENCODEINE PHOSPHATE | 1 | 300/60 MG , EVERY 3 TO 4 HRS PRN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125821861 | 12582186 | 1 | Chronic obstructive pulmonary disease |
| 125821861 | 12582186 | 2 | Asthma |
| 125821861 | 12582186 | 3 | Blood pressure measurement |
| 125821861 | 12582186 | 4 | Chronic obstructive pulmonary disease |
| 125821861 | 12582186 | 5 | Asthma |
| 125821861 | 12582186 | 6 | Gastrooesophageal reflux disease |
| 125821861 | 12582186 | 7 | Back pain |
| 125821861 | 12582186 | 9 | Anxiety |
| 125821861 | 12582186 | 10 | Depression |
| 125821861 | 12582186 | 11 | Bone disorder |
| 125821861 | 12582186 | 12 | Urinary tract infection |
| 125821861 | 12582186 | 13 | Constipation |
| 125821861 | 12582186 | 14 | Multiple allergies |
| 125821861 | 12582186 | 15 | Back pain |
| 125821861 | 12582186 | 16 | Multiple allergies |
| 125821861 | 12582186 | 17 | Vitamin supplementation |
| 125821861 | 12582186 | 18 | Lung disorder |
| 125821861 | 12582186 | 19 | Constipation |
| 125821861 | 12582186 | 20 | Glaucoma |
| 125821861 | 12582186 | 22 | Wheezing |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125821861 | 12582186 | Device malfunction | |
| 125821861 | 12582186 | Dyspnoea | |
| 125821861 | 12582186 | Intentional product misuse | |
| 125821861 | 12582186 | Osteoporosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125821861 | 12582186 | 1 | 20160629 | 0 | ||
| 125821861 | 12582186 | 2 | 20160629 | 0 |